skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nuclear magnetic resonance contrast agents

Patent Application ·
OSTI ID:5408240

This invention relates to the field of nuclear magnetic resonance imaging and nuclear magnetic resonance spectroscopy, also known simply as magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). MRI and MRS are particularly useful in medical research and diagnosis. MRI may be used in addition to x-ray imaging. This invention concerns a family of contrast agents for use in magnetic resonance imaging and a method of enhancing the contrast of magnetic resonance images of an object by incorporating a contrast agent of this invention into the object prior to forming the images or during formation of the images. A contrast agent of this invention is a paramagnetic lanthanide hexaazamacrocyclic molecule, where a basic example has the formula LnC{sub 16}H{sub 14}N{sub 6}. Important applications of the invention are in medical diagnosis, treatment, and research, where images of portions of a human body are formed by means of magnetic resonance techniques. 2 figs.

Research Organization:
Los Alamos National Lab., NM (United States)
Sponsoring Organization:
USDOE; USDOE, Washington, DC (United States)
DOE Contract Number:
W-7405-ENG-36
Assignee:
Dept. of Energy
Patent Number(s):
PATENTS-US-A7301678
Application Number:
ON: DE91016889; PPN: US 7-301678
OSTI ID:
5408240
Country of Publication:
United States
Language:
English